JP4091553B2 - Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant - Google Patents
Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant Download PDFInfo
- Publication number
- JP4091553B2 JP4091553B2 JP2004019306A JP2004019306A JP4091553B2 JP 4091553 B2 JP4091553 B2 JP 4091553B2 JP 2004019306 A JP2004019306 A JP 2004019306A JP 2004019306 A JP2004019306 A JP 2004019306A JP 4091553 B2 JP4091553 B2 JP 4091553B2
- Authority
- JP
- Japan
- Prior art keywords
- acid betaine
- antiseptic
- antiseptic disinfectant
- cosmetics
- pharmaceuticals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002421 anti-septic effect Effects 0.000 title claims description 36
- 239000000645 desinfectant Substances 0.000 title claims description 28
- 239000002537 cosmetic Substances 0.000 title claims description 20
- 235000013305 food Nutrition 0.000 title claims description 15
- 239000003814 drug Substances 0.000 title description 21
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 70
- 229960003237 betaine Drugs 0.000 claims description 38
- 239000002253 acid Substances 0.000 claims description 20
- 229940031723 1,2-octanediol Drugs 0.000 claims description 18
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 18
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical group CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- DHYWSAPLZYWZSZ-UHFFFAOYSA-N 2-(dimethylazaniumyl)hexadecanoate Chemical compound CCCCCCCCCCCCCCC(N(C)C)C(O)=O DHYWSAPLZYWZSZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000417 fungicide Substances 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 230000000855 fungicidal effect Effects 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- 239000000203 mixture Substances 0.000 description 16
- 239000000126 substance Substances 0.000 description 14
- 230000002401 inhibitory effect Effects 0.000 description 13
- 238000010586 diagram Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- -1 stearyldimethylamino Chemical group 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000003042 antagnostic effect Effects 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229940064004 antiseptic throat preparations Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000009036 growth inhibition Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 239000004909 Moisturizer Chemical class 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Chemical class 0.000 description 1
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- CUBCNYWQJHBXIY-UHFFFAOYSA-N benzoic acid;2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1O CUBCNYWQJHBXIY-UHFFFAOYSA-N 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 230000002289 effect on microbe Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000015201 grapefruit juice Nutrition 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 239000008311 hydrophilic ointment Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000642 polymer Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Images
Landscapes
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Description
本発明は防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品に係り、その目的は、1,2−オクタンジオールが本来有する抗菌力を増強することのできる防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品を提供することにある。 The present invention relates to an antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant, and the object thereof is to preserve the antiseptic disinfectant capable of enhancing the antibacterial activity inherent in 1,2-octanediol and the antiseptic It is to provide cosmetics, medicines and foods containing a bactericide.
従来より化粧料、医薬品又は食品には、防腐殺菌剤として、メチルパラベン、エチルパラベンなどのパラベン類、安息香酸及びその塩類、サリチル酸及びその塩類、等が用いられており、特にパラベンは頻繁に用いられている。 Conventionally, parabens such as methylparaben and ethylparaben, benzoic acid and salts thereof, salicylic acid and salts thereof, and the like have been used in cosmetics, pharmaceuticals or foods as antiseptic disinfectants, and parabens are particularly frequently used. ing.
しかしながら、上記した従来の防腐殺菌剤は皮膚刺激性が高いなど安全性が低いため、使用濃度範囲が制限されやすいという欠点を有しており、例えば、パラベンや安息香酸塩の使用制限濃度は1%、安息香酸やサリチル酸の使用制限濃度は0.2%とされている。また、pHによる影響を受けやすいため効果の安定性が悪く、更に、界面活性剤などの他の配合成分との併用により、その抗菌力が著しく低下する問題も有している。また、近年これらの防腐殺菌剤に対しアレルギー反応を有する人が増えているため、安全性に対する指向がより高まり、これらの防腐殺菌剤を全く配合してないか、或いはその配合量を低減させた化粧料、医薬品又は食品の需要が高まっている。 However, the above-mentioned conventional antiseptic disinfectants have a drawback that the use concentration range is easily restricted because of low safety such as high skin irritation. For example, the use restriction concentration of paraben and benzoate is 1 %, The limit concentration of benzoic acid and salicylic acid is 0.2%. In addition, since it is easily influenced by pH, the stability of the effect is poor, and further, there is a problem that the antibacterial activity is remarkably lowered by the combined use with other compounding components such as a surfactant. In addition, in recent years, an increasing number of people have an allergic reaction to these antiseptic disinfectants, so the orientation toward safety has increased, and these preservatives / disinfectants have not been blended at all, or the blending amount has been reduced. There is an increasing demand for cosmetics, pharmaceuticals or foods.
そこで、上記の防腐殺菌剤を低減又は排除する試みが種々行われている。例えば、1,2−アルカンジオールからなる防腐殺菌剤(特許文献1参照)や、1,2−オクタンジオールからなる洗浄性又は非洗浄性化粧用保湿静菌剤(特許文献2参照)、1,2−ペンタンジオール又は、ヘキサンジオールを含む外用剤組成物(特許文献3参照)などが開示されている。しかし、1,2−オクタンジオールなどの1,2−アルカンジオールを単独で防腐殺菌剤として用いた場合、非イオン性界面活性剤の存在下では高配合量を要することがあり、さらに、1,2−アルカンジオールを高配合とすると、特有の原料臭が生じ、化粧料などに配合した際の臭いの問題を有していた。
また、1,2−アルカンジオールの抗菌力を向上させるために、1,2−アルカンジオールと他の防腐殺菌剤を組み合わせた例として、1,2−ペンタンジオールと2−フェノキシエタノールからなる外用組成物(特許文献4参照)や1,2−アルカンジオールとパラベンからなる防腐殺菌剤(特許文献5参照)、1,2−アルカンジオールとヒノキチオールからなる外用組成物(特許文献6参照)等が開示されている。
Accordingly, various attempts have been made to reduce or eliminate the above-mentioned antiseptic disinfectant. For example, an antiseptic disinfectant comprising 1,2-alkanediol (see Patent Document 1), a cleansing or non-detergent cosmetic moisturizing bacteriostatic agent comprising 1,2-octanediol (see Patent Document 2), 1, An external preparation composition containing 2-pentanediol or hexanediol (see Patent Document 3) is disclosed. However, when a 1,2-alkanediol such as 1,2-octanediol is used alone as a preservative fungicide, a high blending amount may be required in the presence of a nonionic surfactant. When 2-alkanediol was highly blended, a specific raw material odor was generated, which had a problem of odor when blended in cosmetics and the like.
Moreover, in order to improve the antibacterial activity of 1,2-alkanediol, as an example of combining 1,2-alkanediol and other antiseptic fungicides, an external composition comprising 1,2-pentanediol and 2-phenoxyethanol (See Patent Document 4), antiseptic fungicides composed of 1,2-alkanediol and paraben (see Patent Document 5), compositions for external use composed of 1,2-alkanediol and hinokitiol (refer to Patent Document 6), and the like are disclosed. ing.
しかしながら、従来の1,2−アルカンジオールとその他の防腐剤を組み合わせた防腐殺菌剤は、パラベンや安息香酸類等の防腐殺菌剤の配合量を低減又は排除させるために、各薬剤の効果を合わせたものであって、各薬剤の効果を増強させるものではなかった。 However, the conventional antiseptics combining 1,2-alkanediol and other preservatives combined the effects of each agent in order to reduce or eliminate the compounding amount of antiseptics such as parabens and benzoic acids. However, it did not enhance the effect of each drug.
すなわち、請求項1に係る発明は、1,2−オクタンジオールと、アルキルジメチルアミノ酢酸ベタインを含有することを特徴とする防腐殺菌剤に関する。
請求項2に係る発明は、アルキルジメチルアミノ酢酸ベタインが、式(1)で表されるアルキルジメチルアミノ酢酸ベタインであることを特徴とする請求項1に記載の防腐殺菌剤に関する。
請求項3に係る発明は、アルキルジメチルアミノ酢酸ベタインが、ラウリルジメチルアミノ酢酸ベタイン及び/又はミリスチルジメチルアミノ酢酸ベタインであることを特徴とする請求項1に記載の防腐殺菌剤に関する。
請求項4に係る発明は、請求項1〜3のいずれかに記載の防腐殺菌剤を配合したことを特徴とする化粧料、医薬品又は食品に関する。
That is, the invention according to claim 1 relates to an antiseptic disinfectant comprising 1,2-octanediol and alkyldimethylaminoacetic acid betaine.
The invention according to claim 2 relates to the antiseptic disinfectant according to claim 1, wherein the alkyldimethylaminoacetic acid betaine is an alkyldimethylaminoacetic acid betaine represented by the formula (1).
The invention according to claim 3 relates to the antiseptic fungicide according to claim 1, wherein the alkyldimethylaminoacetic acid betaine is lauryldimethylaminoacetic acid betaine and / or myristyldimethylaminoacetic acid betaine.
The invention which concerns on Claim 4 is related with the cosmetics, pharmaceutical, or foodstuff characterized by mix | blending the antiseptic disinfectant in any one of Claims 1-3.
本発明によれば、従来より用いられているパラベン、安息香酸等の防腐殺菌剤を排除あるいは使用量を低減することができ、強力な抗菌力を有する安全性と利用性の高い防腐殺菌剤、及び該防腐殺菌剤を配合する化粧料、医薬品又は食品を提供することができる。 According to the present invention, antibacterial agents such as parabens and benzoic acid that have been conventionally used can be eliminated or used, and the antibacterial agents having high antibacterial activity and high safety and high utility. And cosmetics, pharmaceuticals or foods containing the antiseptic disinfectant.
本発明の防腐殺菌剤は、1,2−オクタンジオールと、アルキルジメチルアミノ酢酸ベタインを含有する。アルキルジメチルアミノ酢酸ベタインとしては、例えば次式2(化2)で表されるものが挙げられ、具体的にはラウリルジメチルアミノ酢酸ベタイン、ミリスチルジメチルアミノ酢酸ベタイン、カプリルジメチルアミノ酢酸ベタイン、ステアリルジメチルアミノ酢酸ベタイン、オレイルジメチルアミノ酢酸ベタイン等を例示することができる。また、ヤシ油アルキル基を有するヤシ油アルキルジメチルアミノ酢酸ベタインであっても良い。これらのうち、式2(化2)中のRが炭素数12〜18のアルキルジメチルアミノ酢酸ベタインが好ましく、炭素数12〜14のラウリルジメチルアミノ酢酸ベタイン、ミリスチルジメチルアミノ酢酸ベタインが特に好ましい。 The antiseptic disinfectant of the present invention contains 1,2-octanediol and alkyldimethylaminoacetic acid betaine. Examples of the alkyldimethylaminoacetic acid betaine include those represented by the following formula 2 (chemical formula 2), specifically, lauryldimethylaminoacetic acid betaine, myristyldimethylaminoacetic acid betaine, capryldimethylaminoacetic acid betaine, stearyldimethylamino. Examples include betaine acetate and oleyldimethylaminoacetic acid betaine. Moreover, the palm oil alkyldimethylaminoacetic acid betaine which has a palm oil alkyl group may be sufficient. Of these, R in formula 2 (Chemical Formula 2) is preferably alkyldimethylaminoacetic acid betaine having 12 to 18 carbon atoms, particularly preferably lauryldimethylaminoacetic acid betaine or myristyldimethylaminoacetic acid betaine having 12 to 14 carbon atoms.
本発明に係る防腐殺菌剤において、第一の成分である1,2−オクタンジオールと、第二の成分であるアルキルジメチルアミノ酢酸ベタインの含有量は特に限定されないが、重量比で0.1:1〜10:1、好ましくは0.2:1〜5:1となるように配合する。1,2−オクタンジオールをアルキルジメチルアミノ酢酸ベタインの10重量倍を超えて配合すると、また、0.1重量倍未満の場合、抗菌力の増強効果が期待できないために好ましくない。 In the antiseptic disinfectant according to the present invention, the content of 1,2-octanediol as the first component and the alkyldimethylaminoacetic acid betaine as the second component is not particularly limited. It mix | blends so that it may become 1-10: 1, Preferably 0.2: 1-5: 1. If 1,2-octanediol is added in an amount exceeding 10 times the weight of alkyldimethylaminoacetic acid betaine, and less than 0.1 times by weight, an antibacterial activity enhancing effect cannot be expected, which is not preferable.
本発明に係る防腐殺菌剤において、第一の成分である1,2−オクタンジオールと、第二の成分であるアルキルジメチルアミノ酢酸ベタインを含有することにより、後述の試験に示されるように、第一の成分と第二の成分との相乗効果によって、抗金力の優れた増強作用が発揮される。したがって、パラベン、安息香酸、サリチル酸のような従来から用いられている防腐殺菌剤を低配合又は配合する必要がなく、極めて安全性の高い防腐殺菌剤を得ることができる。 In the antiseptic disinfectant according to the present invention, by including 1,2-octanediol as the first component and alkyldimethylaminoacetic acid betaine as the second component, as shown in the test described later, Due to the synergistic effect of the first component and the second component, an excellent anti-gold power enhancing action is exhibited. Therefore, it is not necessary to blend or blend conventionally used antiseptics such as parabens, benzoic acid, and salicylic acid, and an extremely safe antiseptic can be obtained.
上述した本発明に係る防腐殺菌剤は、化粧料、医薬品又は食品に配合して使用する。
具体的には、例えば、化粧料としては洗顔料、化粧水、乳液、クリーム、ファンデーション、マスカラ、ネールエナメル、口紅などの皮膚用化粧料、シャンプー、ヘアトリートメント、養毛・育毛料、ヘアクリーム、ヘアローション、ヘアフォーム、パーマネントウェーブ剤などの頭髪化粧料や、しみやそばかすなどの特定の使用目的を有した薬用化粧料(医薬部外品)などを、医薬品としてはにきび治療薬、うがい薬、トローチなどを、さらに食品としてはチューインガム、キャンディー、飲料などを挙げることができる。
The above-described antiseptic disinfectant according to the present invention is used by being blended with cosmetics, pharmaceuticals or foods.
Specifically, for example, as cosmetics, facial cleansers, lotions, emulsions, creams, foundations, mascaras, nail enamels, lipsticks and other skin cosmetics, shampoos, hair treatments, hair nourishing and hair restorers, hair creams, Hair cosmetics such as hair lotions, hair foams, permanent wave agents, and medicinal cosmetics (quasi-drugs) with specific uses such as stains and freckles are used as medicines for treating acne, gargles, Examples of troches and foods include chewing gum, candy, and beverages.
本発明に係る防腐殺菌剤を化粧料、医薬品又は食品に配合する場合、本発明の効果が損なわれない程度に化粧料、医薬品又は食品で通常用いられる成分を適宜任意に配合することができる。例えば、化粧料や医薬品(医薬部外品を含む)の場合、油脂、ロウ類、高級脂肪酸、低級アルコール、高級アルコール、ステロール、脂肪酸エステル、保湿類、界面活性剤、高分子化合物、無機顔料、色素、香料、酸化防止剤、紫外線吸収剤、ビタミン類、収斂剤、美白剤、動植物抽出物、金属イオン封鎖剤、精製水などが挙げられる。
また、食品の場合には、動植物油、多糖類、甘味料、着色料、ガムベースなどを例示することができる。
本発明に係る防腐殺菌剤において、化粧料、医薬品又は食品に配合する場合、本発明に係る防腐殺菌剤の配合量は特に限定されないが、組成物中、0.01〜20重量%、好ましくは0.05〜5重量%配合する。0.01重量%未満の場合は、抗菌効果に劣るために好ましくなく、また、20重量%を超えて配合しても、それ以上の効果が望めないからである。
When the antiseptic disinfectant according to the present invention is blended in cosmetics, pharmaceuticals or foods, components usually used in cosmetics, pharmaceuticals or foods can be arbitrarily blended as appropriate to such an extent that the effects of the present invention are not impaired. For example, in the case of cosmetics and pharmaceuticals (including quasi drugs), fats and oils, waxes, higher fatty acids, lower alcohols, higher alcohols, sterols, fatty acid esters, moisturizers, surfactants, polymer compounds, inorganic pigments, Examples include pigments, fragrances, antioxidants, ultraviolet absorbers, vitamins, astringents, whitening agents, animal and plant extracts, sequestering agents, and purified water.
In the case of food, animal and vegetable oils, polysaccharides, sweeteners, colorants, gum bases and the like can be exemplified.
In the antiseptic disinfectant according to the present invention, when compounded in cosmetics, pharmaceuticals or foods, the compounding amount of the antiseptic disinfectant according to the present invention is not particularly limited, but is 0.01 to 20% by weight in the composition, preferably 0.05 to 5% by weight is blended. When the amount is less than 0.01% by weight, the antibacterial effect is inferior, which is not preferable. Even when the amount exceeds 20% by weight, no further effect can be expected.
実施例1
(供試菌)
供試菌として、大腸菌(Escherichia coli IF03972)、酵母として口腔カンジタ症菌(Candida albicans IFO1594)、カビとしてクロカビ(Aspergillus niger)を用いた。
Example 1
(Test bacteria)
E. coli (Escherichia coli IF03972) was used as a test bacterium, oral candidiasis (Candida albicans IFO1594) was used as a yeast, and black mold (Aspergillus niger) was used as a mold.
(接種用菌液の調製)
接種用菌液としては、大腸菌の場合、寒天培地で35℃で培養後、更にブイヨン培地に移植して35℃で培養した。得られた培養液をブイヨン培地で約108個/mLに希釈したものを接種用菌液とした。
また、酵母の場合、30℃で同様に培養して約107個/mLに希釈したものを、カビの場合は、25℃で培養後にTween 80(ポリオキシエチレン(20)ソルビタンモノオレエート)0.2%加生理食塩水に胞子を懸濁させ約106個/mLに調整したものを接種用菌液とした。
(Preparation of bacterial solution for inoculation)
In the case of Escherichia coli, the bacterial solution for inoculation was cultured on an agar medium at 35 ° C., then transplanted to a bouillon medium and cultured at 35 ° C. A solution obtained by diluting the obtained culture solution to about 10 8 cells / mL with a bouillon medium was used as a bacterial solution for inoculation.
In the case of yeast, the same culture at 30 ° C. and diluted to about 10 7 cells / mL are diluted. In the case of mold, Tween 80 (polyoxyethylene (20) sorbitan monooleate) is cultured after incubation at 25 ° C. what was adjusted to about 10 6 cells / mL suspension of spores was inoculated for bacterial solution 0.2% pressurized saline.
(被験物質の希釈系列の調製)
20w/w%エチルセルソルブを希釈溶媒とし、5,4,3,2.5,2.25,2,1.75,1.5,1.25,1w/v%の1,2−オクタンジオール液を調製した。
また、ラウリルジメチルアミノ酢酸ベタイン液(商品名 NIKKOL AM−301、純分35%、日光ケミカルズ社製)及び、1,2−オクタンジオールとラウリルジメチルアミノ酢酸ベタイン液の等量混合物については、5w/v%の液を倍倍希釈して希釈系列を調製した。
(Preparation of dilution series of test substance)
20,4,3,2.5,2.25,2,1.75,1.5,1.25,1w / v% 1,2-octane with 20 w / w% ethyl cellosolve as the diluent solvent A diol solution was prepared.
Moreover, about lauryl dimethylamino acetic acid betaine liquid (brand name NIKKOL AM-301, pure part 35%, Nikko Chemicals company make) and 1,2 octanediol and an equal amount mixture of lauryl dimethylamino acetic acid betaine liquid, 5 w / A dilution series was prepared by doubling the v% solution.
[最少発育阻止濃度(MIC)の測定]
上記被験物質を含む希釈系列1mLに対して各寒天培地9mLをシャーレに入れ、それぞれについて、上記接種用菌液を約1cmの長さに画線した。培養は、大腸菌については、35℃で行い、2日後の菌の生育の有無を判定した。また、酵母及びカビについては、25℃で培養を行い、3日後の菌の生育の有無を判定した。このとき、生育が認められなかった最小の濃度をMICとして求めた。
結果を表1に示す。
[Measurement of minimum inhibitory concentration (MIC)]
For each 1 mL of the dilution series containing the test substance, 9 mL of each agar medium was placed in a petri dish, and the inoculum for the inoculum was streaked to a length of about 1 cm. Cultivation was performed at 35 ° C. for E. coli, and the presence or absence of growth of the bacteria after 2 days was determined. Moreover, about yeast and mold, it culture | cultivated at 25 degreeC and the presence or absence of the growth of a microbe after 3 days was determined. At this time, the minimum concentration at which no growth was observed was determined as MIC.
The results are shown in Table 1.
(二元最小発育阻止濃度)
得られた1,2−オクタンジオール、ラウリルジメチルアミノ酢酸ベタイン液、及び1,2オクタンジオールとラウリルジメチルアミノ酢酸ベタイン液の等量混合物の各MICを、1,2−オクタンジオール及びラウリルジメチルアミノ酢酸ベタイン液の配合量に対してプロットし、二元最小発育阻止濃度図を求めた。
尚、二元最小発育阻止濃度により、抗菌性を有する二種類の物質を配合した場合の作用効果を判定することができる。具体的には、抗菌性を有する二種類の物質を配合した場合、それにより生ずる作用は、相乗作用、相加作用、拮抗作用に大別される。
相乗作用とは、二薬剤が相乗的に作用し、本来有する抗菌力が更に増強される作用である。相加作用とは、各薬剤の抗菌力が合わさった作用である。拮抗作用とは、一薬剤が他剤の拮抗力を打ち消す場合の作用である。そして、二元最小発育阻止濃度図による方法は、例えば、図1に示すように、A物質とB物質について、それぞれの割合を変えてMICを測定し、グラフから判定する方法である。これによると、A物質のみにおけるMIC(A点)とB物質のみにおけるMIC(B点)とをプロットした点を結び、両物質を併用したときのMICが、この線上より内側にある場合(点C)は、併用により抗菌力が増強された相乗作用であると、線上(点D)にある場合は相加作用であると、線上より外側にある場合(点E)は、一方又は双方の抗菌力を打ち消し抗菌力を減少させる拮抗作用であると判定することができる。
図2〜4にラウリルジメチルアミノ酢酸ベタイン液に関する二元最小発育阻止濃度図を示す。
(Dual minimum inhibitory concentration)
Each MIC of the resulting 1,2-octanediol, lauryl dimethylaminoacetic acid betaine solution, and an equal mixture of 1,2 octanediol and lauryldimethylaminoacetic acid betaine solution was converted into 1,2-octanediol and lauryldimethylaminoacetic acid. Plotting was performed with respect to the amount of the betaine solution, and a binary minimum growth inhibition concentration diagram was obtained.
In addition, the effect at the time of mix | blending two types of substances which have antimicrobial property can be determined with a binary minimum growth inhibitory density | concentration. Specifically, when two types of substances having antibacterial properties are blended, the action caused by the substances is roughly classified into a synergistic action, an additive action, and an antagonistic action.
The synergistic action is an action in which two drugs act synergistically to further enhance the inherent antibacterial power. The additive action is an action in which the antibacterial powers of the respective drugs are combined. An antagonistic action is an action when one drug counteracts the antagonistic power of another drug. Then, the method based on the binary minimum growth inhibition concentration diagram is a method of determining from the graph by measuring the MIC for each of the A substance and B substance while changing their ratios, as shown in FIG. According to this, when the MIC (point A) only for substance A and the MIC (point B) only for substance B are connected, the MIC when both substances are used is on the inside of this line (point C) is a synergistic effect in which the antibacterial activity is enhanced by the combined use, if it is on the line (point D), if it is an additive action, if it is outside the line (point E), either or both It can be determined that the antagonistic action counteracts the antibacterial activity and decreases the antibacterial activity.
2 to 4 show the binary minimum inhibitory concentration diagrams regarding the lauryldimethylaminoacetic acid betaine solution.
実施例2
ラウリルジメチルアミノ酢酸ベタイン液に替え、ミリスチルジメチルアミノ酢酸ベタイン液(商品名 リカビオンA−200、純分30%、新日本理化社製)を用いて実施例1と同様に操作して、表2の各MIC及び図5〜7の二元最小発育阻止濃度図を求めた(表2)。
In place of lauryldimethylaminoacetic acid betaine solution, the same procedure as in Example 1 was performed using myristyldimethylaminoacetic acid betaine solution (trade name: Ricavion A-200, 30% pure, manufactured by Shin Nippon Rika Co., Ltd.). The binary minimum inhibitory concentration diagram of each MIC and FIGS. 5-7 was determined (Table 2).
(抗菌効果の評価)
図2〜7の結果から、1,2−オクタンジオールとアルキルジメチルアミノ酢酸ベタインとを併用すると、種々の菌種に対して1,2−オクタンジオールが本来有する抗菌活性を増強することが分かる。
(Evaluation of antibacterial effect)
From the results of FIGS. 2 to 7, it can be seen that the combined use of 1,2-octanediol and alkyldimethylaminoacetic acid betaine enhances the antibacterial activity inherent to 1,2-octanediol against various bacterial species.
以下、本発明の防腐殺菌剤を配合した化粧料、医薬品及び食品の配合例を示す。尚、配合量は重量%である。
(配合例1:保湿クリーム)
モノラウリン酸デカグリセル 1.0
モノステアリン酸ポリオキシエチレン(15)グリセル 1.0
水素添加大豆リン脂質 1.0
ステアリン酸 4.0
セタノール 2.0
ベヘニルアルコール 2.0
パラフィン 3.0
スクワラン 12.0
ホホバ油 4.0
メチルポリシロキサン 0.2
1,3−ブチレングリコール 3.0
L−アルギニン 0.1
キサンタンガム 0.001
1,2−オクタンジオール 0.25
ミリスチルジメチルアミノ酢酸ベタイン液 0.3
精製水 残分
合計 100.0
Hereinafter, formulation examples of cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant of the present invention will be shown. In addition, a compounding quantity is weight%.
(Formulation example 1: moisturizing cream)
Decaglyceryl monolaurate 1.0
Polyoxyethylene (15) glyceryl monostearate 1.0
Hydrogenated soybean phospholipid 1.0
Stearic acid 4.0
Cetanol 2.0
Behenyl alcohol 2.0
Paraffin 3.0
Squalane 12.0
Jojoba oil 4.0
Methylpolysiloxane 0.2
1,3-butylene glycol 3.0
L-Arginine 0.1
Xanthan gum 0.001
1,2-octanediol 0.25
Myristyldimethylaminoacetic acid betaine solution 0.3
Purified water residue
Total 100.0
(配合例2:親水性軟膏)
アスコルビン酸 0.5
ポリオキシエチレンセチルエーテル 2.0
水素添加大豆リン脂質 1.0
ステアリン酸 4.0
グリセリンモノステアレート 10.0
流動パラフィン 10.0
ワセリン 4.0
セタノール 5.0
プロピレングリコール 5.0
1,2−オクタンジオール 0.5
ラルリルジメチルアミノ酢酸ベタイン液 0.2
精製水 残分
合計 100.0
(Formulation example 2: hydrophilic ointment)
Ascorbic acid 0.5
Polyoxyethylene cetyl ether 2.0
Hydrogenated soybean phospholipid 1.0
Stearic acid 4.0
Glycerol monostearate 10.0
Liquid paraffin 10.0
Vaseline 4.0
Cetanol 5.0
Propylene glycol 5.0
1,2-octanediol 0.5
Laryldimethylaminoacetic acid betaine solution 0.2
Purified water residue
Total 100.0
(配合例3:飲料)
アスコルビン酸 0.5
ブドウ糖液糖 33.0
グレープフルーツ果汁 64.0
1,2−オクタンジオール 0.5
ラルリルジメチルアミノ酢酸ベタイン液 0.1
酸味料 適量
合計 100.0
(Formulation Example 3: Beverage)
Ascorbic acid 0.5
Glucose liquid sugar 33.0
Grapefruit juice 64.0
1,2-octanediol 0.5
Laryldimethylaminoacetic acid betaine solution 0.1
Sour seasoning
Total 100.0
本発明の防腐殺菌剤は、1,2−アルカンジオールが本来有する抗菌力を増強して優れた抗菌活性を有するとともに、高い安全性を有しているので、化粧料、医薬品及び食品などの防腐殺菌剤として好適に用いることができる。 The antiseptic disinfectant of the present invention enhances the antibacterial activity inherent to 1,2-alkanediol and has an excellent antibacterial activity, as well as high safety. Therefore, the antiseptic of cosmetics, pharmaceuticals, foods, etc. It can be suitably used as a disinfectant.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004019306A JP4091553B2 (en) | 2004-01-28 | 2004-01-28 | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004019306A JP4091553B2 (en) | 2004-01-28 | 2004-01-28 | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005213164A JP2005213164A (en) | 2005-08-11 |
JP4091553B2 true JP4091553B2 (en) | 2008-05-28 |
Family
ID=34903556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004019306A Expired - Lifetime JP4091553B2 (en) | 2004-01-28 | 2004-01-28 | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4091553B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4629354B2 (en) * | 2004-02-25 | 2011-02-09 | 三洋化成工業株式会社 | Surfactant composition |
JP4889283B2 (en) * | 2005-11-11 | 2012-03-07 | 株式会社Adeka | Antibacterial composition and cosmetics and cleaning agents containing the same |
-
2004
- 2004-01-28 JP JP2004019306A patent/JP4091553B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2005213164A (en) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2004028520A1 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JPWO2004028519A1 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4091559B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4091498B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4091566B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4294505B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP3774219B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4091557B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP3965628B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP5013765B2 (en) | Antiseptic disinfectant, cosmetics, pharmaceuticals or foods containing the antiseptic disinfectant | |
JP4091553B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4086794B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4315831B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4781188B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4294511B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4090415B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP3635578B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4086758B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4535744B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4166162B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP2007145748A (en) | Antiseptic sterilizer, cosmetic or medicine containing the antiseptic sterilizer, and method for antiseptic sterilization | |
JP4044005B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4294393B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant | |
JP4294637B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals or foods containing the antiseptic disinfectant | |
JP3643373B2 (en) | Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061110 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20071225 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080218 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080228 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4091553 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110307 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140307 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20170307 Year of fee payment: 9 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |